ALS Drug Development Webinar Series Part 5: Preclinical Development of Potential Therapies

Join us for the fifth installment of the NEALS webinar series on ALS drug development moderated by Dr. Jinsy Andrews from Columbia University. This series will include talks on the preclinical development of potential therapies, the regulatory pathway, the science of trials, ethical considerations, the clinical trial site level overview, and the importance of patient engagement.

In this webinar, Dr. Bowser and Dr. Lagier-Tourenne will discuss the preclinical development of potential therapies.